Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last $20.37 USD
Change Today -0.19 / -0.92%
Volume 299.8K
BRKR On Other Exchanges
As of 8:10 PM 07/2/15 All times are local (Market data is delayed by at least 15 minutes).

bruker corp (BRKR) Snapshot

Previous Close
Day High
Day Low
52 Week High
07/24/14 - $24.50
52 Week Low
11/7/14 - $17.26
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for BRUKER CORP (BRKR)

bruker corp (BRKR) Related Bloomberg News

View More Bloomberg News

bruker corp (BRKR) Related Businessweek News

No Related Businessweek News Found

bruker corp (BRKR) Details

Bruker Corporation, together with its subsidiaries, designs, manufactures, sells, and services proprietary life science and materials research systems, and associated products worldwide. It operates through two segments, Bruker Scientific Instruments, and Bruker Energy & Supercon Technologies. The company offers life science and materials research systems and associated products used in life science research, pharmaceuticals, applied markets, nanotechnology, cell biology, clinical research, microbiology, and in-vitro diagnostics. Its technology platforms include magnetic resonance technologies, mass spectrometry technologies, gas chromatography technologies, infrared and Raman molecular spectroscopy technologies, X-ray technologies, spark-optical emission spectroscopy, atomic force microscopy, fluorescence optical microscopy, and stylus and optical metrology technology. The company also sells a range of field analytical systems for chemical, biological, radiological, nuclear, and explosive detection; and develops and manufactures low temperature and high temperature superconducting wire products, as well as superconducting wire and superconducting devices for use in magnet technology, physics research, and energy applications. Bruker Corporation’s customer base includes life science, pharmaceutical, biotechnology and molecular diagnostic research companies, academic institutions, advanced materials, and semiconductor industries, as well as government agencies. The company markets its products through direct sales force; and distributors, independent sales representatives, and other representatives. Bruker Corporation was founded in 1991 and is headquartered in Billerica, Massachusetts.

6,100 Employees
Last Reported Date: 02/27/15
Founded in 1991

bruker corp (BRKR) Top Compensated Officers

Chairman, Chief Executive Officer and Preside...
Total Annual Compensation: $598.7K
Interim Chief Financial Officer and Senior Vi...
Total Annual Compensation: $256.5K
President of Bruker Daltonics Division and Pr...
Total Annual Compensation: $717.2K
President of Bruker MAT Group
Total Annual Compensation: $399.5K
President of Bruker BioSpin Group
Total Annual Compensation: $394.0K
Compensation as of Fiscal Year 2014.

bruker corp (BRKR) Key Developments

Bruker Introduces Second-Generation Inspire Nanochemical Imaging Solution

Bruker announced the release of its second-generation Inspire™ infrared (IR) nanocharacterization system, which features 10-nanometer spatial resolution infrared chemical mapping in an easy-to-use, laser-safe package. With IR EasyAlign™, Inspire simplifies scattering scanning near-field optical microscopy (sSNOM), a powerful technique for identifying chemical composition at the nanoscale. For the first time, the high resolution nanoscale chemical mapping now becomes widely accessible. The system expands upon Bruker’s exclusive PeakForce Tapping® technology to provide new information for graphene research, polymers, complex materials and thin films, instantly correlating chemical maps with sample properties, such as modulus, conductivity, and workfunction. Inspire accomplishes all of this at the high spatial resolution, making it an exceptionally powerful and versatile nanochemical characterization system.

Bruker Corporation Presents at 9th Annual Wells Fargo Securities Research, Economics & Strategy 2015 Healthcare Conference, Jun-17-2015

Bruker Corporation Presents at 9th Annual Wells Fargo Securities Research, Economics & Strategy 2015 Healthcare Conference, Jun-17-2015 . Venue: The Intercontinental Boston, Boston, Massachusetts, United States.

Bruker Introduces MALDI Tissuetyper™ Solution

Bruker Corporation announced the launch of the novel MALDI Tissuetypersolution, based on the newrapifleXMALDI-TOF Mass Spectrometry system. The introduction of the revolutionary rapifleX as the new instrument platform for MALDI imaging anatomical pathology research further enhances Bruker’s leadership position for MALDI-TOF-based applications solutions. The new rapifleX system eliminates many previous bottlenecks in mass spectrometry imaging (MSI), with much improved speed, throughput, ease-of-use, robustness and spatial resolution. At the same time, MSI maintenance efforts are reduced to a minimum by a streamlined design of the ion source for maximum uptime and optimized accessibility. The new MALDI Tissuetyper solution based on the rapifleX instrument redefines the key performance measures for MALDI imaging and allows for completely new projects and measurement strategies. The rapifleX system offers by far the high laser repetition rate on the market, combined with the best MALDI imaging spatial resolution. The instrument has a removable, self-aligning ion source for high customer service convenience. The MALDI Tissuetyper solution works up to 20 times faster than traditional MALDI-TOF systems, using Bruker’s break-through, proprietary smartbeam™ 3D laser. The new scanning smartbeam 3D laser provides a fast moving laser-beam which is synchronized with the movement of the MALDI target stage. In combination with the game-changing laser repetition rate of 10 kHz, this architecture allows for real high throughput where MALDI imaging researchers have dramatically increased flexibility in pixel size or target tissue size. Depending on the sample size, typical tissue sections can now be imaged in approximately 30 minutes. Mass spectrometry images from small tissue biopsies are available within a few minutes.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
BRKR:US $20.37 USD -0.19

BRKR Competitors

Market data is delayed at least 15 minutes.

Company Last Change
BioMerieux €96.11 EUR -0.16
FEI Co $82.73 USD -0.22
National Instruments Corp $29.68 USD +0.11
Teledyne Technologies Inc $107.00 USD +0.45
Teradyne Inc $19.43 USD +0.08
View Industry Companies

Industry Analysis


Industry Average

Valuation BRKR Industry Range
Price/Earnings 63.5x
Price/Sales 2.0x
Price/Book 4.8x
Price/Cash Flow 63.2x
TEV/Sales 1.5x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact BRUKER CORP, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at